Delivery Order SPE2DB22D3102-SPE2DB25FK9CP

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $1,308.84 to provide Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.36 firm fixed-price delivery order is for the supply of 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.00 firm fixed price delivery order is for the supply of 4559169460 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $8,208.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, with a completion date of November 10, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.56 firm fixed-price delivery order is for the supply of 4,566,209,977 units of Metoprolol Succinate Extended-Release 50mg Tablets. The contract has an ultimate completion date of October 28, 2024. This award is not designated as a set-aside contract. The contract is associated with a larger Indefinite...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25 mg tablets in quantities of 1,000 per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award, valued at $2,109.25, is a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. This IDC, valued at up to $999,999,999.00,...
This federal contract award is for the delivery of Metoprolol Succinate ER 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,740.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the medication Metoprolol Succinate Extended-Release 100 mg tablets. The contract has a firm fixed price of $5,030.32 and a completion date of May 23, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.38 firm fixed-price delivery order is for the supply of 4,560,481,760 units of Metoprolol Succinate ER 100 mg tablets. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9CP
    Delivery Order

This federal contract award, valued at $1,604.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of metoprolol succinate extended-release tablets, a cardiovascular medication, to support military healthcare programs.

The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/20/25, 2:18 PM